Article · 31 Mar 2025
Review articlePublished 29 May 2023
Endogenous Neurogenesis and Chinese Medicine's Therapeutic Potential: A Potential Stroke Treatment Candidate
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Stroke is the most common cause of adult morbidity and mortality worldwide. Numerous preclinical studies have demonstrated that neural-stem-cell-based stroke treatments have a significant therapeutic potential. A few investigations have affirmed that the compelling parts of conventional Chinese medication can secure and keep up with the endurance, multiplication, and separation of endogenous brain undifferentiated organisms through various targets and components. As a result, a potential treatment option for stroke patients is the use of Chinese medicines to activate and encourage endogenous nerve regeneration and repair. The current understanding of neural stem cell strategies for ischemic strokes and the potential effects of Chinese medicines on neuronal regeneration are summarized in this paper.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Experimental Stroke & Translational Medicine.
Article · 31 Mar 2025
Preclinical to Clinical Translation: Bridging the Gap in Biomedical Research
Article · 31 Mar 2025
Pharmacogenomics: Personalizing Medicine Through Genetic Insights
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Experimental Stroke & Translational Medicine
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Abu Ahmed”